怡邦行控股(00599.HK)建議“4供1”供股及每手買賣單位更改為16000股
格隆匯10月21日丨怡邦行控股(00599.HK)公吿,公司建議以認購價每股供股股份0.192港元按每持有4股現有股份獲發1股供股股份的基準進行供股,透過向合資格股東發行最多1.5億股供股股份以籌集最多約2880萬港元。
供股所得款項淨額估計最多為約2770萬港元,公司擬將建議供股所得款項淨額(i)約15.0百萬港元用於為有關,集團廚房設備及家俬業務的新陳列室及貨倉的估計翻新成本及相關建設開支提供資金;(ii)約9.9百萬港元用於償還銀行貸款;及(iii)約2.8百萬港元用作集團的一般營運資金。
董事會建議將股份於聯交所進行買賣的每手買賣單位由4,000股股份更改為16,000股股份,自2022年12月23日上午九時正起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.